Paradeep Phosphates Limited

NSE:PARADEEP.NS

160.41 (INR) • At close July 4, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q12020 Q1
Revenue 34,940.241,049.238,438.423,774.322,427.425,950.336,830.230,543.336,439.443,984.328,636.924,346.65,306.8827,093.219,346.613,159.915,54211,411.810,464
Cost of Revenue 25,117.531,738.829,495.818,411.516,496.318,709.829,065.225,715.229,83835,027.221,96019,306.67,972.0922,462.214,478.110,093.112,899.88,454.17,756.6
Gross Profit 9,822.79,310.48,942.65,362.85,931.17,240.57,7654,828.16,601.48,957.16,676.95,040-2,665.214,6314,868.53,066.82,642.22,957.72,707.4
Gross Profit Ratio 0.2810.2270.2330.2260.2640.2790.2110.1580.1810.2040.2330.207-0.5020.1710.2520.2330.170.2590.259
Reseach & Development Expenses 0000000011.8190008.4000000
General & Administrative Expenses 000000005,042.6970001,894.848000000
Selling & Marketing Expenses 00000000106.0030008.352000000
SG&A 689.205,3154,354.43,871.43,8574,626.9582.45,148.74,663.24,3053,016.61,903.2347.4357.3299.1364.41,020.71,056.6
Other Expenses 06,595.50192.1300.386.4109.9191.8696.855.461.297.3155.1663.429.544.3000
Operating Expenses 689.26,595.55,3154,354.45,028.34,967.25,711.85,685.96,2005,710.45,330.73,775.9-3,514.72,778.72,413.52,257.72,081.11,8861,939.6
Operating Income 9,133.52,714.93,627.61,008.41,215.12,359.72,163.1-6641,103.33,297.21,4111,264.11,004.591,914.452,487.8857.6560.11,071.7767.8
Operating Income Ratio 0.2610.0660.0940.0420.0540.0910.059-0.0220.030.0750.0490.0520.1890.0710.1290.0650.0360.0940.073
Total Other Income Expenses Net -6,903.8-512.2-669.6-866.8-1,472.461-738.2-849.5-737.1-797.6-823-662.6-415.4-483.79-151.6-113-22.7-1,984.2-310.5-1,442.3
Income Before Tax 2,229.72,202.72,958141.6262.41,535.11,203.7-1,592.9305.72,423.7683.6848.71,532.711,700.72,342786.4293.6761.2208.5
Income Before Tax Ratio 0.0640.0540.0770.0060.0120.0590.033-0.0520.0080.0550.0240.0350.2890.0630.1210.060.0190.0670.02
Income Tax Expense 629.4615.2683.478.347.4445.9309.4-393.5205.9620.4172.6221164.2423.9590.1187.2216.8260.967.6
Net Income 1,600.31,587.52,276.353.82151,089.2894.3-1,199.499.81,803.3511627.71,368.511,276.81,751.9599.276.8500.3140.9
Net Income Ratio 0.0460.0390.0590.0020.010.0420.024-0.0390.0030.0410.0180.0260.2580.0470.0910.0460.0050.0440.013
EPS 1.961.952.790.0660.261.341.1-1.470.122.210.630.932.422.222.150.740.140.870.24
EPS Diluted 1.961.942.790.0660.261.341.1-1.470.122.210.630.932.382.222.150.740.140.870.24
EBITDA 3,890.2253,715.24,4031,662.81,781.22,911.32,669.9-193.81,602.93,772.91,875.11,669.71,179.32,146.22,712.81,071.7767.5831,273943.2
EBITDA Ratio 0.1110.0910.1150.070.0790.1120.072-0.0060.0440.0860.0650.0690.2220.0790.140.0810.0490.1120.09